American Health Intel Rules. Money. Medicine. Decoded daily.
Subscribe
← All editions
Following a story · 2 updates · 1 ledger call

DEA proposes 1 mg/g threshold to place kratom-derived opioids 7-OH and mitragynine pseudoindoxyl in Schedule I

Aug 7, 2026 – Oct 14, 2026

  1. Aug 7, 2026 The Regulator Rule

    DEA's waiting period to schedule concentrated 7-OH kratom as Schedule I has expired

    The DEA's July 6 Federal Register notice said it would not issue its order temporarily placing concentrated 7-hydroxymitragynine into Schedule I before August 5, and that date has now passed, meaning a nationwide ban on products above 0.05 percent concentration could take effect any day.

    Read this issue →
  2. Oct 14, 2026 The Regulator Rule Latest

    DEA proposes 1 mg/g threshold to place kratom-derived opioids 7-OH and mitragynine pseudoindoxyl in Schedule I

    A DEA notice published October 14 sets a 1 milligram per gram concentration line above which 7-hydroxymitragynine and mitragynine pseudoindoxyl would be classified Schedule I under a temporary two-year order that can be published on or after November 13.

    Read this issue →